JACQUITA JORDAN: Open Payments
NPI 1730558834 · FOUNTAIN, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,583 in 137 payments from 22 companies in 2025. Trend: 2023 $8,227 · 2024 $21,891 · 2025 $19,583
Speaker / faculty: $11,152Consulting: $4,280Food & beverage: $2,825Travel & lodging: $1,114Education: $211
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 44 | $16,150 |
| E.R. Squibb & Sons, L.L.C. | 9 | $1,566 |
| Neurocrine BioSciences, Inc. | 25 | $445 |
| Alkermes, Inc. | 11 | $261 |
| ABBVIE INC. | 5 | $233 |
| Indivior Inc. | 8 | $170 |
| Otsuka America Pharmaceutical, Inc. | 7 | $160 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Braeburn Inc. | 4 | $71 |
| Janssen Pharmaceuticals, Inc | 2 | $68 |
Products named: UZEDY, INGREZZA, MAVYRET, ARISTADA, SUBLOCADE, AUSTEDO XR, REXULTI, CAPLYTA.
Industry payments across CO — which companies pay providers there.
